1
|
Morshed K, Polz-Dacewicz M, Szymański M
and Polz D: Short-fragment PCR assay for highly sensitive
broad-spectrum detection of human papillomaviruses in laryngeal
squamous cell carcinoma and normal mucosa: Clinico-pathological
evaluation. Eur Arch Otorhinolaryngol. 265(Suppl 1): S89–S96. 2008.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ramroth H, Schoeps A, Rudolph E, Dyckhoff
G, Plinkert P, Lippert B, Feist K, Delank KW, Scheuermann K, Baier
G, et al: Factors predicting survival after diagnosis of laryngeal
cancer. Oral Oncol. 47:1154–1158. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan
Y, Tang W, Yu L and Zhao S: Cloning, expression and
characterization of the human NOB1 gene. Mol Biol Rep. 32:185–189.
2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Fatica A, Oeffinger M, Dlakić M and
Tollervey D: Nob1p is required for cleavage of the 3′ end of 18S
rRNA. Mol Cell Biol. 23:1798–1807. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Fatica A, Tollervey D and Dlakić M: PIN
domain of Nob1p is required for D-site cleavage in 20S pre-rRNA.
RNA. 10:1698–1701. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lamanna AC and Karbstein K: Nob1 binds the
single-stranded cleavage site D at the 3′-end of 18S rRNA with its
PIN domain. Proc Natl Acad Sci USA. 106:14259–14264. 2009.
View Article : Google Scholar
|
8
|
Tone Y and Toh-E A: Nob1p is required for
biogenesis of the 26S proteasome and degraded upon its maturation
in Saccharomyces cerevisiae. Genes Dev. 16:3142–3157. 2002.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Veith T, Martin R, Wurm JP, Weis BL,
Duchardt-Ferner E, Safferthal C, Hennig R, Mirus O, Bohnsack MT,
Wöhnert J, et al: Structural and functional analysis of the
archaeal endonuclease Nob1. Nucleic Acids Res. 40:3259–3274. 2012.
View Article : Google Scholar :
|
10
|
Li XY, Luo QF, Li J, Wei CK, Kong XJ,
Zhang JF and Fang L: Clinical significance of NOB1 expression in
breast infiltrating ductal carcinoma. Int J Clin Exp Pathol.
6:2137–2144. 2013.PubMed/NCBI
|
11
|
Zhang X, Zhang D, Qu F, Hong Y, Cao J, Pan
X, Li L, Huang Y, Huang H, Yin L, et al: Knockdown of NOB1
expression inhibits the malignant transformation of human prostate
cancer cells. Mol Cell Biochem. 396:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Liu K, Gu MM, Chen HL and You QS: NOB1 in
non-small-cell lung cancer: Expression profile and clinical
significance. Pathol Oncol Res. 20:461–466. 2014. View Article : Google Scholar
|
13
|
Huang WY, Chen DH, Ning L and Wang LW:
siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog
inhibits proliferation and growth of breast cancer cells. Asian Pac
J Cancer Prev. 13:1823–1827. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Liu Y, Huang H, Yuan B, Zhuang LY, Luo TP
and Zhang Q: Lentivirus-mediated knockdown of NOB1 suppresses the
proliferation of colon cancer cells. Z Gastroenterol. 52:429–435.
2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lin Y, Peng S, Yu H, Teng H and Cui M:
RNAi-mediated down-regulation of NOB1 suppresses the growth and
colony-formation ability of human ovarian cancer cells. Med Oncol.
29:311–317. 2012. View Article : Google Scholar
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods.
25:402–408. 2001. View Article : Google Scholar
|
17
|
Jia JW, Liu AQ, Wang Y, Zhao F, Jiao LL
and Tan J: Evaluation of NIN/RPN12 binding protein inhibits
proliferation and growth in human renal cancer cells. Tumour Biol.
36:1803–1810. 2015. View Article : Google Scholar
|
18
|
Lu Z, Guo Q, Shi A, Xie F and Lu Q:
Downregulation of NIN/RPN12 binding protein inhibit the growth of
human hepatocellular carcinoma cells. Mol Biol Rep. 39:501–507.
2012. View Article : Google Scholar
|
19
|
Wang H, Li P and Zhao B: Knockdown of NOB1
expression by RNAi inhibits cellular proliferation and migration in
human gliomas. Gene. 528:146–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
He XW, Feng T, Yin QL, Jian YW and Liu T:
NOB1 is essential for the survival of RKO colorectal cancer cells.
World J Gastroenterol. 21:868–877. 2015.PubMed/NCBI
|
21
|
Li Y, Ma C, Qian M, Wen Z, Jing H and Qian
D: Downregulation of NOB1 suppresses the proliferation and tumor
growth of non-small cell lung cancer in vitro and in vivo. Oncol
Rep. 31:1271–1276. 2014.PubMed/NCBI
|
22
|
Meng W, Wang PS, Liu J, Xue S, Wang GM,
Meng XY and Chen G: Adenovirus-mediated siRNA targeting NOB1
inhibits tumor growth and enhances radiosensitivity of human
papillary thyroid carcinoma in vitro and in vivo. Oncol Rep.
32:2411–2420. 2014.PubMed/NCBI
|
23
|
Liu J, Dong BF, Wang PS, Ren PY, Xue S,
Zhang XN, Han Z and Chen G: Silencing NOB1 enhances doxorubicin
antitumor activity of the papillary thyroid carcinoma in vitro and
in vivo. Oncol Rep. 33:1551–1559. 2015.PubMed/NCBI
|
24
|
Che JP, Li W, Yan Y, Liu M, Wang GC, Li
QY, Yang B, Yao XD and Zheng JH: Expression and clinical
significance of the nin one binding protein and p38 MAPK in
prostate carcinoma. Int J Clin Exp Pathol. 6:2300–2311.
2013.PubMed/NCBI
|
25
|
Chen B, Liu J, Wu D, Qin Y, Peng C, Li C
and Wang J: Gene silencing of NOB1 by lentivirus suppresses growth
and migration of human osteosarcoma cells. Mol Med Rep.
9:2173–2179. 2014.PubMed/NCBI
|
26
|
Bode AM and Dong Z: The functional
contrariety of JNK. Mol Carcinog. 46:591–598. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Maundrell K, Antonsson B, Magnenat E,
Camps M, Muda M, Chabert C, Gillieron C, Boschert U, Vial-Knecht E,
Martinou JC, et al: Bcl-2 undergoes phosphorylation by c-Jun
N-terminal kinase/stress-activated protein kinases in the presence
of the constitutively active GTP-binding protein Rac1. J Biol Chem.
272:25238–25242. 1997. View Article : Google Scholar : PubMed/NCBI
|
28
|
Yu C, Minemoto Y, Zhang J, Liu J, Tang F,
Bui TN, Xiang J and Lin A: JNK suppresses apoptosis via
phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol
Cell. 13:329–340. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Brahim S, Aroui S, Abid K and Kenani A:
Involvement of C-jun NH2-terminal kinase and apoptosis
induced factor in apoptosis induced by deglycosylated bleomycin in
laryngeal carcinoma cells. Cell Biol Int. 33:964–970. 2009.
View Article : Google Scholar : PubMed/NCBI
|